Collegium to Participate in H.C. Wainwright Global Investment Conference
Rhea-AI Summary
Collegium Pharmaceutical (Nasdaq: COLL) announced its participation at the H.C. Wainwright Global Investment Conference, scheduled for May 23-26, 2022, at the Fontainebleau Miami Beach Hotel. Collegium’s presentation is set for May 24, 2022, at 3:30 pm ET. The company is focused on improving the lives of those with serious medical conditions and is headquartered in Stoughton, Massachusetts. For more information, visit www.collegiumpharma.com.
Positive
- None.
Negative
- None.
News Market Reaction – COLL
In the trading session that priced this news, COLL gained 1.29%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
STOUGHTON, Mass., May 17, 2022 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company, today announced that management will present at the H.C. Wainwright Global Investment Conference being held at the Fontainebleau Miami Beach Hotel from May 23-26, 2022.
Details of the event are as follows:
Presentation Date and Time: Tuesday, May 24, 2022, at 3:30 pm ET
About Collegium Pharmaceutical, Inc.
Collegium is a diversified, specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions. Collegium’s headquarters are located in Stoughton, Massachusetts. For more information, please visit the Company’s website at www.collegiumpharma.com.
Contact:
Alex Dasalla
Head of Investor Relations
adasalla@collegiumpharma.com
